BlackRock’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.7M | Buy |
5,770,692
+107,993
| +2% | +$1M | ﹤0.01% | 2379 |
|
|
2025
Q1 | $38.1M | Buy |
5,662,699
+1,537,711
| +37% | +$10.3M | ﹤0.01% | 2497 |
|
|
2024
Q4 | $43.8M | Buy |
4,124,988
+143,206
| +4% | +$1.52M | ﹤0.01% | 2497 |
|
|
2024
Q3 | $58.2M | Buy |
3,981,782
+222,918
| +6% | +$3.26M | ﹤0.01% | 2349 |
|
|
2024
Q2 | $45.5M | Buy |
3,758,864
+2,929,851
| +353% | +$35.5M | ﹤0.01% | 2429 |
|
|
2024
Q1 | $20.5M | Buy |
829,013
+438,377
| +112% | +$10.8M | ﹤0.01% | 2933 |
|
|
2023
Q4 | $4.18M | Buy |
390,636
+348,107
| +819% | +$3.72M | ﹤0.01% | 3683 |
|
|
2023
Q3 | $355K | Sell |
42,529
-783
| -2% | -$6.54K | ﹤0.01% | 4449 |
|
|
2023
Q2 | $343K | Buy |
43,312
+1,773
| +4% | +$14K | ﹤0.01% | 4509 |
|
|
2023
Q1 | $207K | Sell |
41,539
-429
| -1% | -$2.14K | ﹤0.01% | 4675 |
|
|
2022
Q4 | $92.7K | Buy |
41,968
+516
| +1% | +$1.14K | ﹤0.01% | 4982 |
|
|
2022
Q3 | $183K | Buy |
41,452
+2,241
| +6% | +$9.89K | ﹤0.01% | 4909 |
|
|
2022
Q2 | $126K | Sell |
39,211
-357
| -0.9% | -$1.15K | ﹤0.01% | 5077 |
|
|
2022
Q1 | $224K | Sell |
39,568
-1,071
| -3% | -$6.06K | ﹤0.01% | 4994 |
|
|
2021
Q4 | $527K | Buy |
40,639
+131
| +0.3% | +$1.7K | ﹤0.01% | 4781 |
|
|
2021
Q3 | $986K | Buy |
40,508
+17,622
| +77% | +$429K | ﹤0.01% | 4497 |
|
|
2021
Q2 | $396K | Sell |
22,886
-89,965
| -80% | -$1.56M | ﹤0.01% | 4679 |
|
|
2021
Q1 | $3.82M | Buy |
112,851
+41,099
| +57% | +$1.39M | ﹤0.01% | 3999 |
|
|
2020
Q4 | $695K | Buy |
+71,752
| New | +$695K | ﹤0.01% | 4212 |
|